Search results for "Highlights"
Patients with type 2 diabetes at higher risk for AKI, even without pre-existing kidney disease
The authors of the retrospective study called for additional research on the pathogenesis of acute kidney injury (AKI) and the associated risk factors, such as medications, in diabetic patients.
9 Oct 2020
Consensus report aims to define remission of diabetes
An international expert group convened by the American Diabetes Association proposed that the criterion for diabetes remission be an HbA1c level below 6.5%, measured at least three months after glucose-lowering drugs are stopped.
10 Sep 2021
Recent-onset diabetes, weight loss associated with increased pancreatic cancer risk
Unintentional weight loss and weight loss in those with a body mass index already in the normal range were particularly associated with risk of pancreatic cancer among patients with recent-onset diabetes, a study found.
11 Sep 2020
Adverse events associated with SGLT-2 inhibitors do not appear dose-dependent
In a systematic review and meta-analysis, no difference was seen between high- and low-dose sodium-glucose cotransporter-2 (SGLT-2) inhibitors in overall safety or specific safety outcomes, other than a mild increased risk for adverse events with higher doses of canagliflozin.
11 Sep 2020
Few diabetes, hypertension patients get recommended testing for kidney disease
Only 21% of patients with diabetes, hypertension, or both underwent urine albumin-to-creatinine ratio testing in a year, despite guideline recommendations, a large recent study found.
13 Aug 2021
Patient-led titration of basal insulin appears effective in type 2 diabetes
A meta-analysis of six studies found that patient-led titration was associated with lower HbA1c and fasting plasma glucose levels than physician-led titration, although hypoglycemia risk and body weight were slightly higher.
14 Aug 2020
Spotlight on amputations
Recent studies analyzed data on lower-extremity amputations among patients with diabetes, including recent trends in this complication and its associated mortality, effects of the pandemic, and relationships with diabetes drugs.
14 Aug 2020
Pain in diabetes-related polyneuropathy associated with adverse events, death
Patients with type 2 diabetes who had no diabetes-related polyneuropathy, diabetes-related polyneuropathy with pain, and diabetes-related polyneuropathy without pain were compared in an industry-funded retrospective study.
10 Jul 2020
ADA updates 2021 Standards of Care to address latest research on diagnosis, treatment
The American Diabetes Association (ADA) 2021 Standards of Medical Care in Diabetes now reflect new data on teplizumab and sodium-glucose cotransporter-2 inhibitors, as well as the effects of dapagliflozin and finerenone on patients with chronic kidney disease.
9 Jul 2021
Health care organizations push for diabetes self-management education and support
A new consensus report urged clinicians to discuss self-management education and support with all diabetes patients and provide referrals at four critical points in care, including diagnosis.
12 Jun 2020